Ticker > Company >

Himalaya Nutravedics share price

Himalaya Nutravedics India Ltd.

  521   0   0 BSE: 544943 SECTOR: Pharmaceuticals & Drugs

119.95
+5.70 (4.99%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 119.95

Today's Low

₹ 119.9

52 Week High

₹ 135.1

52 Week Low

₹ 111

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 105.63 Cr.

Enterprise Value

₹ 109.32 Cr.

No. of Shares

0.88 Cr.

P/E

14.29

P/B

2.46

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  48.69

CASH

₹ 1.45 Cr.

DEBT

₹ 5.13 Cr.

Promoter Holding

68.13 %

EPS (TTM)

₹  8.39

Sales Growth

105.12%

ROE

63.88 %

ROCE

52.17%

Profit Growth

231.11 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year105.12%
3 Year176.11%
5 YearNA

Profit Growth

1 Year231.11%
3 Year320.48%
5 YearNA

ROE%

1 Year63.88%
3 Year52.06%

ROCE %

1 Year52.17%
3 Year38.04%

Debt/Equity

0.3133

Price to Cash Flow

-27.55

Interest Cover Ratio

22.3021

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 68.13 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 176.106692482359% for the Past 3 years.
  • Company has been maintaining healthy ROE of 52.0621666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 38.0363333333333% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 22.3021.
  • Company’s PEG ratio is 0.129943272019549.
  • Company has a healthy liquidity position with current ratio of 2.7473.
  • The company has a high promoter holding of 68.13%.

 Limitations

  • Company has negative cash flow from operations of -3.8344.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 2.05 14.43 21 43.07
Total Expenditure 1.81 13.49 18.01 34.96
Operating Profit 0.23 0.94 2.99 8.11
Other Income 0 0 0 0.05
Interest 0.03 0.18 0.32 0.35
Depreciation 0.06 0.16 0.42 0.33
Exceptional Items 0 0 0 0
Profit Before Tax 0.15 0.59 2.25 7.48
Tax 0.05 0.17 0.02 0.09
Net Profit 0.1 0.43 2.23 7.39
Adjusted EPS (Rs.) 0.8 3.42 3.72 11.72

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 0.83 0.83 4 6.31
Total Reserves 0.1 0.53 2.76 10.07
Borrowings 0 0.62 0.54 0
Other N/C liabilities 0.01 0.04 0.1 0.14
Current liabilities 2.29 4.07 3.42 7.9
Total Liabilities 3.24 6.09 10.82 24.42
Assets
Net Block 0.58 1.5 1.29 1.03
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 0
Investments 0 0.02 0.03 0.07
Loans & Advances 0 0 0.38 1.62
Other N/C Assets 0 0 0 0
Current Assets 2.66 4.58 9.12 21.7
Total Assets 3.24 6.09 10.82 24.42
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 0.15 0.59 2.25 7.48
Adjustment 0.09 0.34 0.74 0.63
Changes in Assets & Liabilities -1.38 -1.32 -4.36 -11.85
Tax Paid -0.04 -0.17 -0.02 -0.09
Operating Cash Flow -1.18 -0.55 -1.39 -3.83
Investing Cash Flow -0.64 -1.1 -0.23 -0.06
Financing Cash Flow 1.87 1.84 1.44 5.27
Net Cash Flow 0.05 0.19 -0.18 1.38

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q1FY27

Company News

Himalaya Nutravedics Stock Price Analysis and Quick Research Report. Is Himalaya Nutravedics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Himalaya Nutravedics. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Himalaya Nutravedics has a PE ratio of 14.2943966441833 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Himalaya Nutravedics has ROA of 41.9458% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Himalaya Nutravedics has a Current ratio of 2.7473.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Himalaya Nutravedics has a ROE of 63.8753%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Himalaya Nutravedics has a Debt to Equity ratio of 0.3133 which means that the company has low proportion of debt in its capital.

  • Sales growth: Himalaya Nutravedics has reported revenue growth of 105.1175% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Himalaya Nutravedics for the current financial year is 18.8195274859233%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Himalaya Nutravedics is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Himalaya Nutravedics is Rs 8.3914. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Himalaya Nutravedics in Ticker for free. Also, one can get the intrinsic value of Himalaya Nutravedics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Himalaya Nutravedics FAQs

Q1. What is Himalaya Nutravedics share price today?
Ans: The current share price of Himalaya Nutravedics is Rs 119.95.

Q2. What is the market capitalisation of Himalaya Nutravedics?
Ans: Himalaya Nutravedics has a market capitalisation of Rs 105.6318084 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Himalaya Nutravedics?
Ans: The PE ratio of Himalaya Nutravedics is 14.2943966441833 and the P/B ratio of Himalaya Nutravedics is 2.46362583284725, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Himalaya Nutravedics share?
Ans: The 52-week high share price of Himalaya Nutravedics is Rs 135.1, and the 52-week low share price of Himalaya Nutravedics is Rs 111.

Q5. Does Himalaya Nutravedics pay dividends?
Ans: Currently, Himalaya Nutravedics does not pay dividends. Dividend yield of Himalaya Nutravedics is around 0%.

Q6. What are the face value and book value of Himalaya Nutravedics shares?
Ans: The face value of Himalaya Nutravedics shares is Rs 10, while the book value per share of Himalaya Nutravedics is around Rs 48.6884. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Himalaya Nutravedics?
Ans: Himalaya Nutravedics has a total debt of Rs 5.1318 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Himalaya Nutravedics?
Ans: The ROE of Himalaya Nutravedics is 63.8753% and ROCE of Himalaya Nutravedics is 52.1659%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Himalaya Nutravedics a good buy for the long term?
Ans: The Himalaya Nutravedics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Himalaya Nutravedics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Himalaya Nutravedics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Himalaya Nutravedics’s financials?
Ans: You can review Himalaya Nutravedics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Himalaya Nutravedics
X